Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 5:15 PM
Ignite Modification Date:
2025-12-25 @ 2:53 PM
NCT ID:
NCT04381650
Pre Assignment Details:
Participants with a diagnosis of advanced or metastatic solid tumors were enrolled in this study consisting of Phase 1b (Dose Escalation cohorts), and Phase 2 (Dose Expansion cohorts) periods to receive TAK-981 and pembrolizumab.
Recruitment Details:
Participants took part in the study at various investigative sites throughout the world from 17 August 2020 to 29 October 2024.
Study:
NCT04381650
Study Brief:
Results Section:
NCT04381650